Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ling Chen, Jing Zhong, Saiqun Li, Weihua Li, Bowen Wang, Yuqing Deng & Jin Yuan. (2018) The long-term effect of tacrolimus on alkali burn-induced corneal neovascularization and inflammation surpasses that of anti-vascular endothelial growth factor. Drug Design, Development and Therapy 12, pages 2959-2969.
Read now
Read now
Michael L Rolfsen, Nicholas E Frisard, Ethan M Stern, Timothy P Foster, Partha S Bhattacharjee, Harris E McFerrin Jr, Christian Clement, Paulo C Rodriguez, Walter J Lukiw, Donald R Bergsma, Augusto C Ochoa & James M Hill. (2013) Corneal neovascularization: a review of the molecular biology and current therapies. Expert Review of Ophthalmology 8:2, pages 167-189.
Read now
Read now
Articles from other publishers (18)
Hay Man Saung Hnin Soe, Phyo Darli Maw, Rathapon Asasutjarit, Thorsteinn Loftsson & Phatsawee Jansook. (2023) Tacrolimus/hydroxypropyl-β-cyclodextrin-loaded nanoemulsions stabilized by Zein-Soluplus® nanoparticles for retinal diseases. Journal of Drug Delivery Science and Technology, pages 104936.
Crossref
Crossref
Josefien Hessels, Steven Kroon, Sanne Boerman, Rik C. Nelissen, Jan C. Grutters, Repke J. Snijder, Franck Lebrin, Marco C. Post, Christine L. Mummery & Johannes-Jurgen Mager. (2022) Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study. Journal of Clinical Medicine 11:18, pages 5280.
Crossref
Crossref
Qianwen Shang, Yunpeng Chu, Yanan Li, Yuyi Han, Daojiang Yu, Rui Liu, Zhiyuan Zheng, Lin Song, Jiankai Fang, Xiaolei Li, Lijuan Cao, Zheng Gong, Liying Zhang, Yongjing Chen, Ying Wang, Changshun Shao & Yufang Shi. (2020) Adipose-derived mesenchymal stromal cells promote corneal wound healing by accelerating the clearance of neutrophils in cornea. Cell Death & Disease 11:8.
Crossref
Crossref
Zachary Barry, Bomina Park & Timothy W. Corson. (2020) Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization. Molecules 25:15, pages 3468.
Crossref
Crossref
Xuepeng Zhang, Kaiying Yang, Siyuan Chen & Yi Ji. (2019) Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma. The Journal of Dermatology 46:10, pages 898-901.
Crossref
Crossref
Federica Maggio. (2019) Ocular surface disease in dogs part 2: diagnosis and treatment. Companion Animal 24:6, pages 319-328.
Crossref
Crossref
Yihui Wu, Zhuojun Xu, Ying Yang, Jin Qiu, Meng Yang, Chuangran Wu, Zhipeng Lai, Mingjun Tang, Jian Ge, Keming Yu & Jing Zhuang. (2019) Tetramethylpyrazine (TMP) ameliorates corneal neovascularization via regulating cell infiltration into cornea after alkali burn. Biomedicine & Pharmacotherapy 109, pages 1041-1051.
Crossref
Crossref
Danial Roshandel, Medi Eslani, Alireza Baradaran-Rafii, Albert Y. Cheung, Khaliq Kurji, Sayena Jabbehdari, Alejandra Maiz, Setareh Jalali, Ali R. Djalilian & Edward J. Holland. (2018) Current and emerging therapies for corneal neovascularization. The Ocular Surface 16:4, pages 398-414.
Crossref
Crossref
Xinyao Liu, Shurong Wang, Xuanzhong Wang, Jiaming Liang & Yan Zhang. (2017) Recent drug therapies for corneal neovascularization. Chemical Biology & Drug Design 90:5, pages 653-664.
Crossref
Crossref
Yifeng Yu, Jing Zhong, Lulu Peng, Bowen Wang, Saiqun Li, Haixiang Huang, Yuqing Deng, Henan Zhang, Ruhui Yang, Changyun Wang & Jin Yuan. (2017) Tacrolimus downregulates inflammation by regulating pro-/anti-inflammatory responses in LPS-induced keratitis. Molecular Medicine Reports 16:5, pages 5855-5862.
Crossref
Crossref
Anna-Maria Szczesniak, Richard F. Porter, James T. Toguri, Joanna Borowska-Fielding, Simon Gebremeskel, Anuja Siwakoti, Brent Johnston, Christian Lehmann & Melanie E.M. Kelly. (2017) Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy. Neuropharmacology 113, pages 627-638.
Crossref
Crossref
Erdal UysalMehmet Dokur. (2017) Comparison of effects of the tacrolimus and cyclosporine A on the colon anastomosis recovery of rats. Annals of Surgical Treatment and Research 92:6, pages 402.
Crossref
Crossref
Erdem Eriş, Nurşen Yüksel, Dilara Pirhan, Aynur Karadenizli, Mehmet Aslan, Gülçin Gacar, Gülay Erman, Cansu Subaş, Hüseyin Uzuner, Demir Kürşat Yldz & Erdal Karaöz. (2016) Evaluation of Effect of Topical Tacrolimus Treatment on Herpetic Stromal Keratitis in a Rat Model. Eye & Contact Lens: Science & Clinical Practice 42:3, pages 163-170.
Crossref
Crossref
Jin-Heung Park, Choun-Ki Joo & Sung Kun Chung. (2015) Comparative Study of Tacrolimus and Bevacizumab on Corneal Neovascularization in Rabbits. Cornea 34:4, pages 449-455.
Crossref
Crossref
Ryuichi Nishimura, Sho Nishioka, Ikuma Fujisawa, Hitoshi Shiku, Miki Shimada, Satoshi Sekiguchi, Keisei Fujimori, Akira Ushiyama, Tomokazu Matsue, Noriaki Ohuchi, Susumu Satomi & Masafumi Goto. (2013) Tacrolimus Inhibits the Revascularization of Isolated Pancreatic Islets. PLoS ONE 8:4, pages e56799.
Crossref
Crossref
Rike Michels, Stephan Michels & Stephan Kaminski. (2012) Effect of Combined Topical Heparin and Steroid on Corneal Neovascularization in Children. Ophthalmic Surgery, Lasers and Imaging Retina 43:6, pages 452-458.
Crossref
Crossref
Jung-Yoon Choe, Seung-Jin Lee, Sung-Hoon Park & Seong-Kyu Kim. (2012) Le tacrolimus (FK506) inhibe l’expression induite par l’interleukine-1β, de l’angiopoïétine-1, du récepteur Tie-2 et du facteur de croissance vasculaire endothéliale, en agissant par inhibition des voies JNK et p38 dans les synoviocytes de type fibroblastique au cours de la polyarthrite rhumatoïde. Revue du Rhumatisme 79:2, pages 125-131.
Crossref
Crossref
Jung-Yoon Choe, Seung-Jin Lee, Sung-Hoon Park & Seong-Kyu Kim. (2012) Tacrolimus (FK506) inhibits interleukin-1β-induced angiopoietin-1, Tie-2 receptor, and vascular endothelial growth factor through down-regulation of JNK and p38 pathway in human rheumatoid fibroblast-like synoviocytes. Joint Bone Spine 79:2, pages 137-143.
Crossref
Crossref